Get the latest NGSX - NeurogesX Incorporated stock market performance data and financial news.
Read Jim Cramer's take on NeurogesX Incorporated (NGSX) and get his latest thoughts on the company?s performance and outlook
Get the latest NGSX - NeurogesX Incorporated together with stock market performance data and financial news.
Get the latest NGSX - NeurogesX Incorporated stock market performance data and financial news.
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
It's not clear how this tiny biotech's pain patch can compete with a host of rivals, large and small.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10451693/1/biotech-mailbag-neurogesx-patchy-at-best.html
A study shows that its NGX-4010 reduced pain for eight weeks in patients with postherpetic neuralgia.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10377710/1/neurogesx-climbs-on-pain-patch-data.html
InterMune rises on an FDA approval.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10377765/1/tuesdays-health-winners-losers.html
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10600357/1/ceo-sells-108m-worth-of-guess.html
NeurogesX shares rise as Food and Drug Administration approves Qutenza pain patch. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10627890/1/neurogesx-shares-rise-following-fda-approval.html
Connect with TheStreet